Skip to product information
1 of 2

SANOFI SpA

Enterogermina 4 Billion/5 Ml 20 Vials

Enterogermina 4 Billion/5 Ml 20 Vials

Regular price €26,90 EUR
Regular price Sale price €26,90 EUR
Sale Sold out
Tax included. Shipping calculated at checkout.
Logo Farmaci da banco

PRODUCT NET WEIGHT

100ml

EAN

013046089

MINSAN

013046089

View full details

Enterogermina 4 Billion/5 Ml 20 Vials lactic ferments with probiotic action for the treatment and prophylaxis of intestinal dysbiosis. Helps restore intestinal balance thanks to the spores of Bacillus clausii polyantibiotic resistant.

Enterogermina 4 Billion/5 Ml 20 Vials is indicated for:

  • Prevention and treatment of alterations in the normal balance of intestinal bacterial flora (intestinal dysbiosis) and vitamin deficiencies in the body resulting from an imbalance in intestinal bacterial flora (endogenous dysvitaminosis).

  • Adjuvant therapy for the restoration of the intestinal microbial flora , altered during antibiotic or chemotherapy treatments.

  • Treatment of acute and chronic gastrointestinal diseases of infants caused by intoxication or alterations in the normal balance of intestinal bacterial flora (intestinal dysmicrobism) or vitamin deficiencies in the body (dysvitaminosis).

 

ACTIVE INGREDIENTS

Active ingredients contained in Enterogermina 4 Billion/5 Ml 20 Vials - What is the active ingredient in Enterogermina 4 Billion/5 Ml 20 Vials?

One vial contains, active substance: spores of polyantibiotic-resistant Bacillus clausii (strains SIN, O/C, T, N/R) 4 billion. For the full list of excipients, see section 6.1.

 

EXCIPIENTS

Composition of Enterogermina 4 Billion/5 Ml 20 Vials - What does Enterogermina 4 Billion/5 Ml 20 Vials contain?

Vials: purified water.

 

DIRECTIONS

Therapeutic indications Enterogermina 4 Billion/5 Ml 20 Vials - Why is Enterogermina 4 Billion/5 Ml 20 Vials used? What is it used for?

Treatment and prophylaxis of intestinal dysmicrobism and consequent endogenous dysvitaminosis. Adjuvant therapy for the restoration of intestinal microbial flora, altered during antibiotic or chemotherapy treatments. Acute and chronic gastro-intestinal disorders in infants, attributable to intoxications or intestinal dysmicrobism and dysvitaminosis.

 

CONTRAINDICATIONS SIDE EFFECTS

Contraindications Enterogermina 4 Billion/5 Ml 20 Vials - When should Enterogermina 4 Billion/5 Ml 20 Vials not be used?

Hypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1.

 

DOSAGE

Quantity and method of taking Enterogermina 4 Billion/5 Ml 20 Vials - How is Enterogermina 4 Billion/5 Ml 20 Vials taken?

Dosage. Adults: 1 vial per day. Infants and children: 1 vial per day. Method of administration: take the contents of the vial as is or diluted in water or other drinks (e.g. milk, tea, orange juice). This medicine is for oral use only. Do not inject or administer in any other way (see section 4.4).

 

CONSERVATION

Storage Enterogermina 4 Billion/5 Ml 20 Vials - How is Enterogermina 4 Billion/5 Ml 20 Vials stored?

Store below 30 degrees C.

 

WARNINGS

Warnings Enterogermina 4 Billion/5 Ml 20 Vials - It is important to know that about Enterogermina 4 Billion/5 Ml 20 Vials:

Special warnings. Bacteremia/sepsis: Cases of bacteremia, septicaemia and sepsis have been reported in immunocompromised or critically ill patients and in preterm infants since the introduction into the market. In some critically ill patients, the outcome was fatal. Enterogermina should be avoided in these groups of patients (see section 4.8). This medicinal product is for oral use only. Do not inject or administer by other routes. Incorrect use of the medicinal product has caused serious anaphylactic reactions such as anaphylactic shock. Precautions for use: during antibiotic therapy, it is advisable to administer the preparation in the interval between one and the other antibiotic administration. Any visible corpuscles in the vials of Enterogermina are due to aggregates of Bacillus clausii spores; therefore, they do not indicate an altered product. Shake the vial before use.

 

INTERACTIONS

Interactions Enterogermina 4 Billion/5 Ml 20 Vials - Which medicines or foods can modify the effect of Enterogermina 4 Billion/5 Ml 20 Vials?'

No interaction studies have been performed.

 

SIDE EFFECTS

Like all medicines, Enterogermina 4 Billion/5 Ml 20 Vials can cause side effects - What are the side effects of Enterogermina 4 Billion/5 Ml 20 Vials?

The following undesirable effects have been observed during treatment with this medicinal product, classified according to the MedDRA organ class and frequency categories: very common (>=1/10); common (>=1/100, <1/10); uncommon (>=1/1,000, <1/100); rare (>=1/10,000, <1/1,000); very rare <1/10,000); not known (frequency cannot be estimated from the available data). Infections and infestations. Not known: bacteraemia, septicaemia and sepsis (in immunocompromised or severely ill patients) (see section 4.4). Skin and subcutaneous tissue disorders. Not known: hypersensitivity reactions, including rash, urticaria and angioedema. Reporting of suspected adverse reactions. Reporting of suspected adverse reactions that occur after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-avverse.

 

PREGNANCY AND BREASTFEEDING

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking Enterogermina 4 Billion/5 Ml 20 Vials.

Pregnancy: There are no data available on the use of Enterogermina in pregnant women; therefore, it is not possible to draw conclusions on the safety of using Enterogermina during pregnancy. Enterogermina should be used during pregnancy only if the potential benefits for the mother outweigh the potential risks, including those for the fetus. Breastfeeding: There are no data available on the use of Enterogermina during breastfeeding regarding the composition of breast milk and the effects on the child. It is not possible to draw conclusions on the safety of using Enterogermina during breastfeeding. Enterogermina should be used during breastfeeding only if the potential benefits for the mother outweigh the potential risks, including those for the breastfed child. Fertility: There are no data available on the effect of Enterogermina on human fertility.

  • HELP CENTER

  • SHIPPING

    Shipping in Italy 24/48H
    Delivery also on Saturday and Sunday
    Free over €49.90


    Shipping in Europe 24/72H
    Free over €80


    Shipping to UK 24/72H
    Free over €150

  • SAFETY

    The security of your data matters to us!


    We are fully compliant with the European GDPR regarding Privacy and Processing of personal data.


    Payments you make on our site are 100% safe and guaranteed.

  • RETURNS

    Fast returns through do-it-yourself portal and 14 days to reconsider.


    Fast and free replacements for incorrect or non-compliant products delivered.

1 of 4

Responsibility for content
This sheet contains information that is not intended to replace a diagnosis or medical advice, as only a doctor can write any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.

Please note
The names of the products, the ingredients and the percentages indicated in the descriptions are purely indicative, they could be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting in real time to such updates, the photos and technical information of the products inserted on Dottortili.com may differ from those reported on the label or otherwise disseminated by the manufacturing companies. The only identification element is the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines all responsibility for any errors, omissions or failure to update the same. Dottortili.com does not assume responsibility for damages of any nature that may arise from access to the published information.

Data source: Farmadati Italia
Website: https://www.farmadati.it/

The Farmadati Italia Database is used by almost all pharmacies, parapharmacies, herbalists, health shops, large-scale retail trade, computerized doctors, etc. thanks to the company's historical guarantee of reliability, seriousness and professionalism on the national territory.

The Farmadati Italia Srl management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO/IEC 27001:2017 for information security management systems.